Table of Contents 1 Market Overview 1.1 Cancer Treatment Drugs Introduction 1.2 Market Analysis by Type 1.2.1 Chemotherapy 1.2.2 Targeted Therapy 1.2.3 Immunotherapy (Biologic Therapy) 1.2.4 Hormonal Therapy 1.2.5 Others 1.3 Market Analysis by Applications 1.3.1 Blood Cancer 1.3.2 Breast Cancer 1.3.3 Gastrointestinal Cancer 1.3.4 Prostate Cancer 1.3.5 Respiratory/Lung Cancer 1.3.6 Other Cancers 1.4 Market Analysis by Regions 1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey) 1.4.1.1 Germany Market States and Outlook (2012-2022) 1.4.1.2 France Market States and Outlook (2012-2022) 1.4.1.3 UK Market States and Outlook (2012-2022) 1.4.1.4 Italy Market States and Outlook (2012-2022) 1.4.1.5 Russia Market States and Outlook (2012-2022) 1.4.1.6 Turkey Market States and Outlook (2012-2022) 1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran) 1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022) 1.4.2.2 UAE Market States and Outlook (2012-2022) 1.4.2.3 Israel Market States and Outlook (2012-2022) 1.4.2.4 Iran Market States and Outlook (2012-2022) 1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria) 1.4.3.1 South Africa Market States and Outlook (2012-2022) 1.4.3.2 Nigeria Market States and Outlook (2012-2022) 1.4.3.3 Egypt Market States and Outlook (2012-2022) 1.4.3.4 Algeria Market States and Outlook (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Roche 2.1.1 Business Overview 2.1.2 Cancer Treatment Drugs Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Novartis 2.2.1 Business Overview 2.2.2 Cancer Treatment Drugs Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Celgene 2.3.1 Business Overview 2.3.2 Cancer Treatment Drugs Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Amgen 2.4.1 Business Overview 2.4.2 Cancer Treatment Drugs Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Johnson & Johnson 2.5.1 Business Overview 2.5.2 Cancer Treatment Drugs Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Bristol-Myers Squibb 2.6.1 Business Overview 2.6.2 Cancer Treatment Drugs Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Takeda 2.7.1 Business Overview 2.7.2 Cancer Treatment Drugs Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Eli Lilly 2.8.1 Business Overview 2.8.2 Cancer Treatment Drugs Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Pfizer 2.9.1 Business Overview 2.9.2 Cancer Treatment Drugs Type and Applications 2.9.2.1 Type 1 2.9.2.2 Type 2 2.9.3 Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 AstraZeneca 2.10.1 Business Overview 2.10.2 Cancer Treatment Drugs Type and Applications 2.10.2.1 Type 1 2.10.2.2 Type 2 2.10.3 AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.11 Astellas 2.11.1 Business Overview 2.11.2 Cancer Treatment Drugs Type and Applications 2.11.2.1 Type 1 2.11.2.2 Type 2 2.11.3 Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.12 Sanofi 2.12.1 Business Overview 2.12.2 Cancer Treatment Drugs Type and Applications 2.12.2.1 Type 1 2.12.2.2 Type 2 2.12.3 Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.13 Bayer 2.13.1 Business Overview 2.13.2 Cancer Treatment Drugs Type and Applications 2.13.2.1 Type 1 2.13.2.2 Type 2 2.13.3 Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.14 Merck & Co. 2.14.1 Business Overview 2.14.2 Cancer Treatment Drugs Type and Applications 2.14.2.1 Type 1 2.14.2.2 Type 2 2.14.3 Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.15 Biogen Idec 2.15.1 Business Overview 2.15.2 Cancer Treatment Drugs Type and Applications 2.15.2.1 Type 1 2.15.2.2 Type 2 2.15.3 Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.16 Kyowa Hakko Kirin 2.16.1 Business Overview 2.16.2 Cancer Treatment Drugs Type and Applications 2.16.2.1 Type 1 2.16.2.2 Type 2 2.16.3 Kyowa Hakko Kirin Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.17 Otsuka 2.17.1 Business Overview 2.17.2 Cancer Treatment Drugs Type and Applications 2.17.2.1 Type 1 2.17.2.2 Type 2 2.17.3 Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.18 Teva 2.18.1 Business Overview 2.18.2 Cancer Treatment Drugs Type and Applications 2.18.2.1 Type 1 2.18.2.2 Type 2 2.18.3 Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.19 Eisai 2.19.1 Business Overview 2.19.2 Cancer Treatment Drugs Type and Applications 2.19.2.1 Type 1 2.19.2.2 Type 2 2.19.3 Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.20 Merck KGaA 2.20.1 Business Overview 2.20.2 Cancer Treatment Drugs Type and Applications 2.20.2.1 Type 1 2.20.2.2 Type 2 2.20.3 Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.21 Ipsen 2.21.1 Business Overview 2.2.2 Cancer Treatment Drugs Type and Applications 2.21.2.1 Type 1 2.21.2.2 Type 2 2.21.3 Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.22 AbbVie 2.22.1 Business Overview 2.22.2 Cancer Treatment Drugs Type and Applications 2.22.2.1 Type 1 2.22.2.2 Type 2 2.22.3 AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.23 Gilead Sciences 2.23.1 Business Overview 2.23.2 Cancer Treatment Drugs Type and Applications 2.23.2.1 Type 1 2.23.2.2 Type 2 2.23.3 Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 EMEA Cancer Treatment Drugs Market Competition, by Manufacturer 3.1 EMEA Cancer Treatment Drugs Sales and Market Share by Manufacturer 3.2 EMEA Cancer Treatment Drugs Revenue and Market Share by Manufacturer 3.3 EMEA Cancer Treatment Drugs Price by Manufacturer (2016-2017) 3.4 Market Concentration Rate 3.4.1 Top 3 Cancer Treatment Drugs Manufacturer Market Share 3.4.2 Top 5 Cancer Treatment Drugs Manufacturer Market Share 3.5 Market Competition Trend 4 EMEA Cancer Treatment Drugs Market Analysis by Regions 4.1 EMEA Cancer Treatment Drugs Sales, Revenue and Market Share by Regions 4.1.1 EMEA Cancer Treatment Drugs Sales by Regions (2012-2017) 4.1.2 EMEA Cancer Treatment Drugs Revenue by Regions (2012-2017) 4.2 Europe Cancer Treatment Drugs Sales and Growth (2012-2017) 4.3 Middle East Cancer Treatment Drugs Sales and Growth (2012-2017) 4.4 Africa Cancer Treatment Drugs Sales and Growth (2012-2017) 5 Europe Cancer Treatment Drugs by Countries, Type, Application and Manufacturers 5.1 Europe Cancer Treatment Drugs Sales, Revenue and Market Share by Countries 5.1.1 Europe Cancer Treatment Drugs Sales by Countries (2012-2017) 5.1.2 Europe Cancer Treatment Drugs Revenue by Countries (2012-2017) 5.1.3 Germany Cancer Treatment Drugs Sales and Growth (2012-2017) 5.1.4 France Cancer Treatment Drugs Sales and Growth (2012-2017) 5.1.5 UK Cancer Treatment Drugs Sales and Growth (2012-2017) 5.1.6 Russia Cancer Treatment Drugs Sales and Growth (2012-2017) 5.1.7 Italy Cancer Treatment Drugs Sales and Growth (2012-2017) 5.1.8 Turkey Cancer Treatment Drugs Sales and Growth (2012-2017) 5.2 Europe Cancer Treatment Drugs Sales and Revenue (value) by Manufacturers (2016-2017) 5.2.1 Europe Cancer Treatment Drugs Sales by Manufacturers (2016-2017) 5.2.2 Europe Cancer Treatment Drugs Revenue by Manufacturers (2016-2017) 5.3 Europe Cancer Treatment Drugs Sales by Type (2012-2017) 5.4 Europe Cancer Treatment Drugs Sales by Application (2012-2017) 6 Middle East Cancer Treatment Drugs by Countries, Type, Application and Manufacturers 6.1 Middle East Cancer Treatment Drugs Sales, Revenue and Market Share by Countries 6.1.1 Middle East Cancer Treatment Drugs Sales by Countries (2012-2017) 6.1.2 Middle East Cancer Treatment Drugs Revenue by Countries (2012-2017) 6.1.3 Saudi Arabia Cancer Treatment Drugs Sales and Growth (2012-2017) 6.1.4 Israel Cancer Treatment Drugs Sales and Growth (2012-2017) 6.1.5 UAE Cancer Treatment Drugs Sales and Growth (2012-2017) 6.1.6 Iran Cancer Treatment Drugs Sales and Growth (2012-2017) 6.2 Middle East Cancer Treatment Drugs Sales and Revenue (value) by Manufacturers (2016-2017) 6.2.1 Middle East Cancer Treatment Drugs Sales by Manufacturers (2016-2017) 6.2.2 Middle East Cancer Treatment Drugs Revenue by Manufacturers (2016-2017) 6.3 Middle East Cancer Treatment Drugs Sales by Type (2012-2017) 6.4 Middle East Cancer Treatment Drugs Sales by Application (2012-2017) 7 Africa Cancer Treatment Drugs by Countries, Type, Application and Manufacturers 7.1 Africa Cancer Treatment Drugs Sales, Revenue and Market Share by Countries 7.1.1 Africa Cancer Treatment Drugs Sales by Countries (2012-2017) 7.1.2 Africa Cancer Treatment Drugs Revenue by Countries (2012-2017) 7.1.3 South Africa Cancer Treatment Drugs Sales and Growth (2012-2017) 7.1.4 Nigeria Cancer Treatment Drugs Sales and Growth (2012-2017) 7.1.5 Egypt Cancer Treatment Drugs Sales and Growth (2012-2017) 7.1.6 Algeria Cancer Treatment Drugs Sales and Growth (2012-2017) 7.2 Middle East Cancer Treatment Drugs Sales and Revenue (value) by Manufacturers (2016-2017) 7.2.1 Middle East Cancer Treatment Drugs Sales by Manufacturers (2016-2017) 7.2.2 Middle East Cancer Treatment Drugs Revenue by Manufacturers (2016-2017) 7.3 Middle East Cancer Treatment Drugs Sales by Type (2012-2017) 7.4 Middle East Cancer Treatment Drugs Sales by Application (2012-2017) 8 EMEA Cancer Treatment Drugs Market Segment by Type 8.1 EMEA Cancer Treatment Drugs Sales, Revenue and Market Share by Type (2012-2017) 8.1.1 EMEA Cancer Treatment Drugs Sales and Market Share by Type (2012-2017) 8.1.2 EMEA Cancer Treatment Drugs Revenue and Market Share by Type (2012-2017) 8.2 Chemotherapy Sales Growth and Price 10.2.1 EMEA Chemotherapy Sales Growth (2012-2017) 10.2.2 EMEA Chemotherapy Price (2012-2017) 8.3 Targeted Therapy Sales Growth and Price 10.3.1 EMEA Targeted Therapy Sales Growth (2012-2017) 10.3.2 EMEA Targeted Therapy Price (2012-2017) 8.4 Immunotherapy (Biologic Therapy) Sales Growth and Price 10.4.1 EMEA Immunotherapy (Biologic Therapy) Sales Growth (2012-2017) 10.4.2 EMEA Immunotherapy (Biologic Therapy) Price (2012-2017) 8.5 Hormonal Therapy Sales Growth and Price 10.5.1 EMEA Hormonal Therapy Sales Growth (2012-2017) 10.5.2 EMEA Hormonal Therapy Price (2012-2017) 8.6 Others Sales Growth and Price 10.6.1 EMEA Others Sales Growth (2012-2017) 10.6.2 EMEA Others Price (2012-2017) 9 EMEA Cancer Treatment Drugs Market Segment by Application 9.1 EMEA Cancer Treatment Drugs Sales Market Share by Application (2012-2017) 9.2 Blood Cancer Sales Growth (2012-2017) 9.3 Breast Cancer Sales Growth (2012-2017) 9.4 Gastrointestinal Cancer Sales Growth (2012-2017) 9.5 Prostate Cancer Sales Growth (2012-2017) 9.6 Respiratory/Lung Cancer Sales Growth (2012-2017) 9.7 Other Cancers Sales Growth (2012-2017) 10 EMEA Cancer Treatment Drugs Market Forecast (2017-2022) 10.1 EMEA Cancer Treatment Drugs Sales, Revenue and Growth Rate (2017-2022) 10.2 Cancer Treatment Drugs Market Forecast by Regions (2017-2022) 10.2.1 Europe Cancer Treatment Drugs Market Forecast by Regions (2017-2022) 10.2.1.1 Germany Cancer Treatment Drugs Sales Forecast 2017-2022 10.2.1.2 France Cancer Treatment Drugs Sales Forecast 2017-2022 10.2.1.3 UK Cancer Treatment Drugs Sales Forecast 2017-2022 10.2.1.4 Russia Cancer Treatment Drugs Sales Forecast 2017-2022 10.2.1.5 Italy Cancer Treatment Drugs Sales Forecast 2017-2022 10.2.1.6 Turkey Cancer Treatment Drugs Sales Forecast 2017-2022 10.2.2 Middle East Market Forecast by Regions (2017-2022) 10.2.2.1 Saudi Arabia Cancer Treatment Drugs Sales Forecast 2017-2022 10.2.2.2 Israel Cancer Treatment Drugs Sales Forecast 2017-2022 10.2.2.3 UAE Cancer Treatment Drugs Sales Forecast 2017-2022 10.2.2.4 Iran Cancer Treatment Drugs Sales Forecast 2017-2022 10.2.3 Africa Market Forecast by Regions (2017-2022) 10.2.3.1 South Africa Cancer Treatment Drugs Sales Forecast 2017-2022 10.2.3.2 Nigeria Cancer Treatment Drugs Sales Forecast 2017-2022 10.2.3.3 Egypt Cancer Treatment Drugs Sales Forecast 2017-2022 10.2.3.4 Algeria Cancer Treatment Drugs Sales Forecast 2017-2022 10.3 Cancer Treatment Drugs Market Forecast by Type (2017-2022) 10.4 Cancer Treatment Drugs Market Forecast by Application (2017-2022) 11 Sales Channel, Distributors, Traders and Dealers 11.1 Sales Channel 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Future Trend 11.2 Distributors, Traders and Dealers 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology 13.2 Analyst Introduction 13.3 Data Source

List of Tables and Figures Figure Cancer Treatment Drugs Picture Table Product Specifications of Cancer Treatment Drugs Figure EMEA Sales Market Share of Cancer Treatment Drugs by Types in 2016 Table Cancer Treatment Drugs Types for Major Manufacturers Figure Chemotherapy Picture Figure Targeted Therapy Picture Figure Immunotherapy (Biologic Therapy) Picture Figure Hormonal Therapy Picture Figure Others Picture Table Cancer Treatment Drugs Sales Market Share by Applications in 2016 Figure Blood Cancer Picture Figure Breast Cancer Picture Figure Gastrointestinal Cancer Picture Figure Prostate Cancer Picture Figure Respiratory/Lung Cancer Picture Figure Other Cancers Picture Figure Germany Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022) Figure France Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022) Figure UK Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022) Figure Italy Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022) Figure Russia Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022) Figure Turkey Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022) Figure Saudi Arabia Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022) Figure UAE Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022) Figure Israel Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022) Figure Iran Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022) Figure South Africa Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022) Figure Nigeria Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022) Figure Egypt Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022) Figure Algeria Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022) Table Roche Basic Information, Manufacturing Base and Competitors Table Roche Cancer Treatment Drugs Type and Applications Table Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Novartis Basic Information, Manufacturing Base and Competitors Table Novartis Cancer Treatment Drugs Type and Applications Table Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Celgene Basic Information, Manufacturing Base and Competitors Table Celgene Cancer Treatment Drugs Type and Applications Table Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Amgen Basic Information, Manufacturing Base and Competitors Table Amgen Cancer Treatment Drugs Type and Applications Table Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors Table Johnson & Johnson Cancer Treatment Drugs Type and Applications Table Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors Table Bristol-Myers Squibb Cancer Treatment Drugs Type and Applications Table Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Takeda Basic Information, Manufacturing Base and Competitors Table Takeda Cancer Treatment Drugs Type and Applications Table Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Eli Lilly Basic Information, Manufacturing Base and Competitors Table Eli Lilly Cancer Treatment Drugs Type and Applications Table Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Cancer Treatment Drugs Type and Applications Table Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca Cancer Treatment Drugs Type and Applications Table AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Astellas Basic Information, Manufacturing Base and Competitors Table Astellas Cancer Treatment Drugs Type and Applications Table Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Sanofi Basic Information, Manufacturing Base and Competitors Table Sanofi Cancer Treatment Drugs Type and Applications Table Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bayer Basic Information, Manufacturing Base and Competitors Table Bayer Cancer Treatment Drugs Type and Applications Table Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Merck & Co. Basic Information, Manufacturing Base and Competitors Table Merck & Co. Cancer Treatment Drugs Type and Applications Table Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Biogen Idec Basic Information, Manufacturing Base and Competitors Table Biogen Idec Cancer Treatment Drugs Type and Applications Table Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors Table Kyowa Hakko Kirin Cancer Treatment Drugs Type and Applications Table Kyowa Hakko Kirin Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Otsuka Basic Information, Manufacturing Base and Competitors Table Otsuka Cancer Treatment Drugs Type and Applications Table Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Teva Basic Information, Manufacturing Base and Competitors Table Teva Cancer Treatment Drugs Type and Applications Table Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Eisai Basic Information, Manufacturing Base and Competitors Table Eisai Cancer Treatment Drugs Type and Applications Table Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Merck KGaA Basic Information, Manufacturing Base and Competitors Table Merck KGaA Cancer Treatment Drugs Type and Applications Table Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Ipsen Basic Information, Manufacturing Base and Competitors Table Ipsen Cancer Treatment Drugs Type and Applications Table Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table AbbVie Basic Information, Manufacturing Base and Competitors Table AbbVie Cancer Treatment Drugs Type and Applications Table AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Gilead Sciences Basic Information, Manufacturing Base and Competitors Table Gilead Sciences Cancer Treatment Drugs Type and Applications Table Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table EMEA Cancer Treatment Drugs Sales by Manufacturer (2016-2017) Figure EMEA Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016 Figure EMEA Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017 Table EMEA Cancer Treatment Drugs Revenue by Manufacturer (2016-2017) Figure EMEA Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016 Figure EMEA Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017 Table EMEA Cancer Treatment Drugs Price by Manufacturer (2016-2017) Figure EMEA Cancer Treatment Drugs Sales and Growth (2012-2017) Figure EMEA Cancer Treatment Drugs Revenue and Growth (2012-2017) Table EMEA Cancer Treatment Drugs Sales by Regions (2012-2017) Table EMEA Cancer Treatment Drugs Sales Market Share by Regions (2012-2017) Figure EMEA Cancer Treatment Drugs Sales Market Share by Regions in 2012 Figure EMEA Cancer Treatment Drugs Sales Market Share by Regions in 2016 Table EMEA Cancer Treatment Drugs Revenue by Regions (2012-2017) Table EMEA Cancer Treatment Drugs Revenue Market Share by Regions (2012-2017) Figure EMEA Cancer Treatment Drugs Revenue Market Share by Regions in 2012 Figure EMEA Cancer Treatment Drugs Revenue Market Share by Regions in 2016 Figure Europe Cancer Treatment Drugs Sales and Growth (2012-2017) Figure Middle East Cancer Treatment Drugs Sales and Growth (2012-2017) Figure Africa Cancer Treatment Drugs Sales and Growth (2012-2017) Figure Europe Cancer Treatment Drugs Revenue and Growth (2012-2017) Table Europe Cancer Treatment Drugs Sales by Countries (2012-2017) Table Europe Cancer Treatment Drugs Sales Market Share by Countries (2012-2017) Figure Europe Cancer Treatment Drugs Sales Market Share by Countries in 2012 Figure Europe Cancer Treatment Drugs Sales Market Share by Countries in 2016 Table Europe Cancer Treatment Drugs Revenue by Countries (2012-2017) Table Europe Cancer Treatment Drugs Revenue Market Share by Countries (2012-2017) Figure Europe Cancer Treatment Drugs Revenue Market Share by Countries in 2012 Figure Europe Cancer Treatment Drugs Revenue Market Share by Countries in 2016 Figure Germany Cancer Treatment Drugs Sales and Growth (2012-2017) Figure France Cancer Treatment Drugs Sales and Growth (2012-2017) Figure UK Cancer Treatment Drugs Sales and Growth (2012-2017) Figure Russia Cancer Treatment Drugs Sales and Growth (2012-2017) Figure Italy Cancer Treatment Drugs Sales and Growth (2012-2017) Figure Turkey Cancer Treatment Drugs Sales and Growth (2012-2017) Table Europe Cancer Treatment Drugs Sales by Manufacturer (2016-2017) Figure Europe Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016 Figure Europe Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017 Table Europe Cancer Treatment Drugs Revenue by Manufacturer (2016-2017) Figure Europe Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016 Figure Europe Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017 Table Europe Cancer Treatment Drugs Sales by Type (2012-2017) Table Europe Cancer Treatment Drugs Sales Share by Type (2012-2017) Table Europe Cancer Treatment Drugs Sales by Application (2012-2017) Table Europe Cancer Treatment Drugs Sales Share by Application (2012-2017) Figure Middle East Cancer Treatment Drugs Revenue and Growth (2012-2017) Table Middle East Cancer Treatment Drugs Sales by Countries (2012-2017) Table Middle East Cancer Treatment Drugs Sales Market Share by Countries (2012-2017) Figure Middle East Cancer Treatment Drugs Sales Market Share by Countries in 2012 Figure Middle East Cancer Treatment Drugs Sales Market Share by Countries in 2016 Table Middle East Cancer Treatment Drugs Revenue by Countries (2012-2017) Table Middle East Cancer Treatment Drugs Revenue Market Share by Countries (2012-2017) Figure Middle East Cancer Treatment Drugs Revenue Market Share by Countries in 2012 Figure Middle East Cancer Treatment Drugs Revenue Market Share by Countries in 2016 Figure Saudi Arabia Cancer Treatment Drugs Sales and Growth (2012-2017) Figure Israel Cancer Treatment Drugs Sales and Growth (2012-2017) Figure UAE Cancer Treatment Drugs Sales and Growth (2012-2017) Figure Iran Cancer Treatment Drugs Sales and Growth (2012-2017) Table Middle East Cancer Treatment Drugs Sales by Manufacturer (2016-2017) Figure Middle East Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016 Figure Middle East Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017 Table Middle East Cancer Treatment Drugs Revenue by Manufacturer (2016-2017) Figure Middle East Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016 Figure Middle East Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017 Table Middle East Cancer Treatment Drugs Sales by Type (2012-2017) Table Middle East Cancer Treatment Drugs Sales Share by Type (2012-2017) Table Middle East Cancer Treatment Drugs Sales by Application (2012-2017) Table Middle East Cancer Treatment Drugs Sales Share by Application (2012-2017) Figure Africa Cancer Treatment Drugs Revenue and Growth (2012-2017) Table Africa Cancer Treatment Drugs Sales by Countries (2012-2017) Table Africa Cancer Treatment Drugs Sales Market Share by Countries (2012-2017) Figure Africa Cancer Treatment Drugs Sales Market Share by Countries in 2012 Figure Africa Cancer Treatment Drugs Sales Market Share by Countries in 2016 Table Africa Cancer Treatment Drugs Revenue by Countries (2012-2017) Table Africa Cancer Treatment Drugs Revenue Market Share by Countries (2012-2017) Figure Africa Cancer Treatment Drugs Revenue Market Share by Countries in 2012 Figure Africa Cancer Treatment Drugs Revenue Market Share by Countries in 2016 Figure South Africa Cancer Treatment Drugs Sales and Growth (2012-2017) Figure Nigeria Cancer Treatment Drugs Sales and Growth (2012-2017) Figure Egypt Cancer Treatment Drugs Sales and Growth (2012-2017) Figure Algeria Cancer Treatment Drugs Sales and Growth (2012-2017) Table Middle East Cancer Treatment Drugs Sales by Manufacturer (2016-2017) Figure Middle East Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016 Figure Middle East Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017 Table Middle East Cancer Treatment Drugs Revenue by Manufacturer (2016-2017) Figure Middle East Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016 Figure Middle East Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017 Table Middle East Cancer Treatment Drugs Sales by Type (2012-2017) Table Middle East Cancer Treatment Drugs Sales Share by Type (2012-2017) Table Middle East Cancer Treatment Drugs Sales by Application (2012-2017) Table Middle East Cancer Treatment Drugs Sales Share by Application (2012-2017) Table EMEA Cancer Treatment Drugs Sales by Type (2012-2017) Table EMEA Cancer Treatment Drugs Sales Share by Type (2012-2017) Table EMEA Cancer Treatment Drugs Revenue by Type (2012-2017) Table EMEA Cancer Treatment Drugs Revenue Share by Type (2012-2017) Figure EMEA Chemotherapy Sales Growth (2012-2017) Figure EMEA Chemotherapy Price (2012-2017) Figure EMEA Targeted Therapy Sales Growth (2012-2017) Figure EMEA Targeted Therapy Price (2012-2017) Figure EMEA Immunotherapy (Biologic Therapy) Sales Growth (2012-2017) Figure EMEA Immunotherapy (Biologic Therapy) Price (2012-2017) Figure EMEA Hormonal Therapy Sales Growth (2012-2017) Figure EMEA Hormonal Therapy Price (2012-2017) Figure EMEA Others Sales Growth (2012-2017) Figure EMEA Others Price (2012-2017) Table EMEA Cancer Treatment Drugs Sales by Application (2012-2017) Table EMEA Cancer Treatment Drugs Sales Share by Application (2012-2017) Figure EMEA Blood Cancer Sales Growth (2012-2017) Figure EMEA Breast Cancer Sales Growth (2012-2017) Figure EMEA Gastrointestinal Cancer Sales Growth (2012-2017) Figure EMEA Prostate Cancer Sales Growth (2012-2017) Figure EMEA Respiratory/Lung Cancer Sales Growth (2012-2017) Figure EMEA Other Cancers Sales Growth (2012-2017) Figure EMEA Cancer Treatment Drugs Sales, Revenue and Growth Rate (2017-2022) Table EMEA Cancer Treatment Drugs Sales Forecast by Regions (2017-2022) Table EMEA Cancer Treatment Drugs Market Share Forecast by Regions (2017-2022) Table Europe Cancer Treatment Drugs Sales Forecast by Regions (2017-2022) Figure Germany Cancer Treatment Drugs Sales Forecast 2017-2022 Figure France Cancer Treatment Drugs Sales Forecast 2017-2022 Figure UK Cancer Treatment Drugs Sales Forecast 2017-2022 Figure Russia Cancer Treatment Drugs Sales Forecast 2017-2022 Figure Italy Cancer Treatment Drugs Sales Forecast 2017-2022 Figure Turkey Cancer Treatment Drugs Sales Forecast 2017-2022 Table Middle East Sales Forecast by Regions (2017-2022) Figure Saudi Arabia Cancer Treatment Drugs Sales Forecast 2017-2022 Figure Israel Cancer Treatment Drugs Sales Forecast 2017-2022 Figure UAE Cancer Treatment Drugs Sales Forecast 2017-2022 Figure Iran Cancer Treatment Drugs Sales Forecast 2017-2022 Table Africa Sales Forecast by Regions (2017-2022) Figure South Africa Cancer Treatment Drugs Sales Forecast 2017-2022 Figure Nigeria Cancer Treatment Drugs Sales Forecast 2017-2022 Figure Egypt Cancer Treatment Drugs Sales Forecast 2017-2022 Figure Algeria Cancer Treatment Drugs Sales Forecast 2017-2022 Table EMEA Cancer Treatment Drugs Sales Forecast by Type (2017-2022) Table EMEA Cancer Treatment Drugs Market Share Forecast by Type (2017-2022) Table EMEA Cancer Treatment Drugs Sales Forecast by Application (2017-2022) Table EMEA Cancer Treatment Drugs Market Share Forecast by Application (2017-2022) Table Distributors/Traders/ Dealers List